Eli Lilly said on Friday that the European Medicines Agency (EMA) has recommended approval of its drug Kisunla for certain ...

Roche’s Elecsys pTau181 test has secured CE Mark approval, marking a development in ruling out Alzheimer's disease.

Aquestive Therapeutics, Inc. (NASDAQ: AQST) ('Aquestive” or the 'Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science ...

David Mooney, who most recently served as Chief of Cyber Protective Services at the Cybersecurity and Infrastructure Security ...

The results represent the current state of operational technology (OT) cybersecurity and highlight opportunities for continued improvement for organizations to secure an ever-expanding IT/OT ...

Potential Positives VCI Global appointed Jane Teh as Chief AI Security Officer, enhancing its leadership in cybersecurity and AI security architecture.

Complementing her corporate leadership, Jane plays an active role in advancing the cybersecurity industry—serving on advisory boards, judging regional hackathons, and speaking at major industry ...

Eli Lilly stock trades at $786.92 after the FDA approves a safer dosing label for Kisunla in early Alzheimer’s. Key trial data support the update.

Fortinet Report: OT Cybersecurity Risk Elevates within Executive Leadership Ranks Provided by GlobeNewswire Jul 9, 2025, 6:00:00 AM ...

David Ajayi, a Nigerian-born data science leader, is redefining clinical research infrastructure and digital health systems in the United States. Recently appointed Associate Director – Clinical Trial ...